Chromium picolinate compositions

• US 6,136,317 A
• Filed: 01/10/2000
• Issued: 10/24/2000
• Est. Priority Date: 08/28/1998
• Status: Expired due to Term

• Current Assignee: Nutrition21 LLC
• Original Assignee: Ambi, Inc. (NXXI, Inc.)
• Inventors: Price, Fredric D., Komorowski, James R., Skluth, Lauren K., de la Harpe, Jon, Chakrin, Lawrence W.
• Primary Examiner(s): HENLEY III, RAYMOND J
• Application Number:
  US09/480,472
• Time in Patent Office: 288 Days
• Field of Search: 424/195.1, 514/188, 514/356
• US Class Current: 424/725
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/4402 only substituted in position 2, e.g. pheniramine, bisacodyl
• CPC Class Codes: A61K 31/455 Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
• CPC Class Codes: A61K 31/555 containing heavy metals, e.g. hemin, hematin, melarsoprol
• CPC Class Codes: A61K 31/60 Salicylic acid; Derivatives thereof
• CPC Class Codes: A61K 31/7004 Monosaccharides having only carbon, hydrogen and oxygen atoms
• CPC Class Codes: A61K 45/06 Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• CPC Class Codes: A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system
• CPC Class Codes: A61P 3/00 Drugs for disorders of the metabolism of the blood or the extracellular fluid A61P7/00

Abstract

Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.

Claims

1. A composition for supplementing dietary chromium and facilitating absorption of essential metals, said composition comprising chromic tripicolinate in combination with picolinic acid.

2. The composition of claim 1, wherein said composition is incorporated into a pharmaceutically acceptable carrier.

3. The composition of claim 2, wherein said carrier is selected from the group consisting of a tablet, capsule, microbead, emulsion, powder, granule, suspension, syrup and elixir.

4. The composition of claim 3, wherein said microbead is a sugar beadlet or microcrystalline cellulose beadlet and said chromic picolinate and said picolinic acid are coated on said beadlet.

5. The composition of claim 1, wherein said chromic picolinate and said picolinic acid are in a ratio of between about 1:

10 and about 10;

1 (w/w).

6. The composition of claim 1, further comprising a cyclooxygenase inhibitor.

7. The composition of claim 1, further comprising an acid.

8. The composition of claim 1, further comprising a mucolytic.

9. The composition of claim 1, further comprising a salicin-containing herb.

10. The composition of claim 3, wherein said tablet, capsule or microbeads are coated with an enteric coating.

11. The composition of claim 1, further comprising nicotinic acid.

12. A composition for supplementing dietary chromium and facilitating absorption of essential metals, said composition comprising chromic tripicolinate in combination with nicotinic acid.

13. The composition of claim 12, wherein said composition is incorporated into a pharmaceutically acceptable carrier.

14. The composition of claim 13, wherein said carrier is selected from the group consisting of a tablet, capsule, microbead, emulsion, powder, granule, suspension, syrup and elixir.

15. The composition of claim 14, wherein said microbead is a sugar beadlet or microcrystalline cellulose beadlet and said chromic picolinate and said picolinic acid are coated on said beadlet.

16. The composition of claim 12, wherein said chromic picolinate and said picolinic acid are in a ratio of between about 1:

10 and about 10;

1 (w/w).

17. The composition of claim 12, further comprising a cyclooxygenase inhibitor.

18. The composition of claim 12, further comprising an acid.

19. The composition of claim 12, further comprising a mucolytic.

20. The composition of claim 12, further comprising a salicin-containing herb.

21. The composition of claim 14, wherein said tablet, capsule or microbeads are coated with an enteric coating.

22. A method for supplementing dietary chromium in an individual, comprising orally administering to said individual a composition comprising chromic tripicolinate in combination with picolinic acid.

23. The method of claim 22, wherein said chromic tripicolinate and said picolinic acid are incorporated into a pharmaceutically acceptable carrier.

24. The method of claim 23, wherein said pharmaceutically acceptable carrier is selected from the group consisting of a tablet, capsule, microbead, emulsion, powder, granule, suspension, syrup and elixir.

25. The method of claim 22, wherein said composition further comprises a cyclooxygenase inhibitor.

26. The method of claim 22, wherein said composition further comprises an acid.

27. The method of claim 22, wherein said composition further comprises a mucolytic.

28. The method of claim 22, wherein said composition further comprises a salicin-containing herb.

29. The method of claim 24, wherein said tablet, capsule or microbeads are coated with an enteric coating.

30. The method of claim 24, wherein said microbead is a sugar beadlet or microcrystalline cellulose beadlet and said chromic tripicolinate and said picolinic acid are coated on said beadlet.

31. The method of claim 22, wherein said effective amount is between about 50 and about 10,000 micrograms.

32. The method of claim 22, wherein said composition further comprises nicotinic acid.

33. A method for supplementing dietary chromium in an individual, comprising orally administering to said individual a composition comprising chromic tripicolinate in combination with nicotinic acid.

34. The method of claim 33, wherein said chromic tripicolinate and said nicotinic acid are incorporated into a pharmaceutically acceptable carrier.

35. The method of claim 34, wherein said pharmaceutically acceptable carrier is selected from the group consisting of a tablet, capsule, microbead, emulsion, powder, granule, suspension, syrup and elixir.

36. The method of claim 33, wherein said composition further comprises a cyclooxygenase inhibitor.

37. The method of claim 33, wherein said composition further comprises an acid.

38. The method of claim 33, wherein said composition further comprises a mucolytic.

39. The method of claim 33, wherein said composition further comprises a salicin-containing herb.

40. The method of claim 35, wherein said tablet, capsule or microbeads are coated with an enteric coating.

41. The method of claim 35, wherein said microbead is a sugar beadlet or microcrystalline cellulose beadlet and said chromic tripicolinate and said picolinic acid are coated on said beadlet.

42. The method of claim 33, wherein said effective amount is between about 50 and about 10,000 micrograms.

43. A method for reducing hyperglycemia and stabilizing serum glucose levels in an individual in need thereof, comprising orally administering to said individual a composition comprising an effective daily hyperglycemia-reducing amount of chromic tripicolinate in combination with picolinic acid.

44. The method of claim 43, wherein said composition further comprises nicotinic acid.

45. The method of claim 43, wherein said composition further comprises a cyclooxygenase inhibitor.

46. The method of claim 43, wherein said composition further comprises an acid.

47. The method of claim 43, wherein said composition further comprises a mucolytic.

48. The method of claim 43, wherein said composition further comprises a salicin-containing herb.

50. The method of claim 48, wherein said composition further comprises a cyclooxygenase inhibitor.

49. A method for reducing hyperglycemia and stabilizing serum glucose levels in an individual in need thereof, comprising orally administering to said individual a composition comprising an effective daily hyperglycemia-reducing amount of chromic tripicolinate in combination with nicotinic acid.

51. The method of claim 49, wherein said composition further comprises an acid.

52. The method of claim 49, wherein said composition further comprises a mucolytic.

53. The method of claim 49, wherein said composition further comprises a salicin-containing herb.

54. A method for increasing lean body mass and reducing body fat of an individual in need thereof, comprising orally administering to said individual a composition comprising an effective, lean body mass-increasing amount of chromic tripicolinate in combination with picolinic acid.

55. The method of claim 54, wherein said composition further comprises nicotinic acid.

56. The method of claim 54, wherein said composition further comprises a cyclooxygenase inhibitor.

57. The method of claim 54, wherein said composition further comprises an acid.

58. The method of claim 54, wherein said composition further comprises a mucolytic.

59. The method of claim 54, wherein said composition further comprises a salicin-containing herb.

60. A method for increasing lean body mass and reducing body fat of an individual in need thereof, comprising orally administering to said individual a composition comprising an effective, lean body mass-increasing amount of chromic tripicolinate in combination with nicotinic acid.

61. The method of claim 60, wherein said composition further comprises a cyclooxygenase inhibitor.

62. The method of claim 60, wherein said composition further comprises an acid.

63. The method of claim 60, wherein said composition further comprises a mucolytic.

64. The method of claim 60, wherein said composition further comprises a salicin-containing herb.

65. A method for reducing high levels of blood serum lipids in an individual in need thereof, comprising orally administering to said individual a composition comprising an effective, lean body mass-increasing amount of chromic tripicolinate in combination with picolinic acid.

66. The method of claim 65, wherein said composition further comprises nicotinic acid.

67. The method of claim 65, wherein said composition further comprises a cyclooxygenase inhibitor.

68. The method of claim 65, wherein said composition further comprises an acid.

69. The method of claim 65, wherein said composition further comprises a mucolytic.

70. The method of claim 65, wherein said composition further comprises a salicin-containing herb.

71. A method for reducing high levels of blood serum lipids in an individual in need thereof, comprising orally administering to said individual a composition comprising an effective, lean body mass-increasing amount of chromic tripicolinate in combination with nicotinic acid.

72. The method of claim 71, wherein said composition further comprises a cyclooxygenase inhibitor.

73. The method of claim 71, wherein said composition further comprises an acid.

74. The method of claim 71, wherein said composition further comprises a mucolytic.

75. The method of claim 71, wherein said composition further comprises a salicin-containing herb.